NaveniFlex Cell MR Atto647N Reference: 60017 Detect proteins, protein-protein interactions, or protein modifications in cell samples. The NaveniFlex Cell MR Atto647N assay is designed to be used with a mouse and rabbit primary antibody pair. Detection with Atto647N fluorophore is included.
Grisnilimab setaritox Reference: HY-P99651 Grisnilimab setaritox (WT1-RTA), is an antihuman T cell antibody (anti-CD7) conjugating with ricin A chain (RTA). RTA is a 30-kDa peptide capable of rapidly in activating ribosomal 60S subunits. Grisnilimab setaritox is cytotoxic to CEM (T-lymphoblastic leukemia) cells in vitro with an ID50 of 53 pM. Grisnilimab setaritox also improves leukemic meningitis model in rhesus monkeys.
NaveniFlex Tissue MR RED Reference: 60027 Detect proteins, protein-protein interactions, or protein modifications. The assay is designed to be used with a mouse and rabbit primary antibody pair. Detection with TEX615 fluorophore is included.
NaveniFlex Tissue MR Atto647N Reference: 60026 Detect proteins, protein-protein interactions, or protein modifications. The assay is designed to be used with a mouse and rabbit primary antibody pair. Detection with Atto647N fluorophore is included.
Oleclumab Reference: HY-P99039 Oleclumab (MEDI9447) is a human IgG1λ anti-CD73 monoclonal antibody that inhibits CD73 function. Oleclumab has an anti-tumor activity.
NaveniBright HRP Reference: 60030 Detect proteins, protein – protein interactions, or protein modifications. The assay is designed to be used with a mouse and a rabbit primary pair. Chromogenic readout with HRP substrate.
Parsatuzumab Reference: HY-P99215 Parsatuzumab (Anti-EGFL7; RG 7414) is a humanized monoclonal antibody, acts as an immunomodulator and binds to EGFL7. Parsatuzumab selectively blocks the interaction between EGFL7 and endothelial cells, potentially inhibiting vascular regrowth and reducing vascular endothelial growth factor (VEGF) inhibition.
Naveni TriFlex Cell MR Reference: 60024 Detect and quantify total protein A, total protein B, and the interaction AB between the two proteins. The assay is designed to be used with a mouse and rabbit primary antibody pair.
Nimotuzumab Reference: HY-P9968 Nimotuzumab is a humanized IgG1 monoclonal antibody targeting EGFR with a KD of 0.21 nM. Nimotuzumab is directed against the extracellular domain of the EGFR blocking the binding to its ligands. Nimotuzumab, a strong antitumor agent, is cytolytic on target tumors by its capacity to cause antibody dependent cell mediated cytotoxicity (ADCC) and complement dependent cytotoxicity (CDC).
NaveniLink Reference: 60028 Conjugate your own primary antibodies. The NaveniLink kit is for conjugating oligos and primary antibodies for the creation of Navenibodies. The kit is compatible with NaveniFlex Cell, NaveniFlex Tissue and NaveniBright
Domagrozumab Reference: HY-P99857 Domagrozumab is an anti-myostatin humanized monoclonal antibody with a KD value of 2.6 pM for human myostatin. Domagrozumab induces muscle anabolic activity. Domagrozumab can be used in research of duchenne muscular dystrophy (DMD).